NCT04621487View on ClinicalTrials.gov

Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 15, 2019

Primary Completion Date

January 15, 2020

Study Completion Date

February 15, 2020

Conditions
Helicobacter Pylori Infection
Interventions
DRUG

Amoxicillin

14 days 1 gr bid

DRUG

Metronidazole

14 days 500 mg bid

DRUG

Clarithromycin

14 days 500 mg bid

DRUG

Pantoprazole 40mg

40 mg bid 14 days

DRUG

according to antibiogram

according to antibiogram

Trial Locations (1)

21000

University hospital Split, Split

All Listed Sponsors
lead

University of Split, School of Medicine

OTHER

NCT04621487 - Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori Infection | Biotech Hunter | Biotech Hunter